[vc_row][vc_column width=»3/4″ css=».vc_custom_1523478190577{padding-right: 35px !important;}»][stm_post_info][vc_column_text]
A landmark cancer drug approved last year seemed to herald a long-anticipated change in the treatment of some tumours: with medicines selected on the basis of molecular markers, rather than the tissue in which the cancer first took root.
Noticia completa
[/vc_column_text][/vc_column][vc_column width=»1/4″][vc_widget_sidebar sidebar_id=»default»][/vc_column][/vc_row]